Cargando…

Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact

PURPOSE: To test the extent of variation among nuclear medicine physicians with respect to staging non-small cell lung cancer with positron emission tomography (PET). PROCEDURES: Two groups of nuclear medicine physicians with different levels of PET experience reviewed 30 PET scans. They were reques...

Descripción completa

Detalles Bibliográficos
Autores principales: Smulders, Sietske A., Gundy, Chad M., van Lingen, Arthur, Comans, Emile F., Smeenk, Frank W J M, Hoekstra, Otto S.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039839/
https://www.ncbi.nlm.nih.gov/pubmed/17610119
http://dx.doi.org/10.1007/s11307-007-0108-1
_version_ 1782137060170137600
author Smulders, Sietske A.
Gundy, Chad M.
van Lingen, Arthur
Comans, Emile F.
Smeenk, Frank W J M
Hoekstra, Otto S.
author_facet Smulders, Sietske A.
Gundy, Chad M.
van Lingen, Arthur
Comans, Emile F.
Smeenk, Frank W J M
Hoekstra, Otto S.
author_sort Smulders, Sietske A.
collection PubMed
description PURPOSE: To test the extent of variation among nuclear medicine physicians with respect to staging non-small cell lung cancer with positron emission tomography (PET). PROCEDURES: Two groups of nuclear medicine physicians with different levels of PET experience reviewed 30 PET scans. They were requested to identify and localize suspicious mediastinal lymph nodes (MLN) using standardized algorithms. Results were compared between the two groups, between individuals, and with expert reading. RESULTS: Overall we found good interobserver agreement (kappa 0.65). Experience with PET translated into a better ability to localize MLN stations (68% vs. 51%, respectively), and experienced readers appeared to be more familiar with translating PET readings into clinically useful statements. CONCLUSIONS: Although our results suggest that clinical experience with PET increases observers’ ability to read and interpret results from PET adequately, there is room for improvement. Experience with PET does not necessarily improve the accuracy of image interpretation.
format Text
id pubmed-2039839
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-20398392007-10-29 Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact Smulders, Sietske A. Gundy, Chad M. van Lingen, Arthur Comans, Emile F. Smeenk, Frank W J M Hoekstra, Otto S. Mol Imaging Biol Research Article PURPOSE: To test the extent of variation among nuclear medicine physicians with respect to staging non-small cell lung cancer with positron emission tomography (PET). PROCEDURES: Two groups of nuclear medicine physicians with different levels of PET experience reviewed 30 PET scans. They were requested to identify and localize suspicious mediastinal lymph nodes (MLN) using standardized algorithms. Results were compared between the two groups, between individuals, and with expert reading. RESULTS: Overall we found good interobserver agreement (kappa 0.65). Experience with PET translated into a better ability to localize MLN stations (68% vs. 51%, respectively), and experienced readers appeared to be more familiar with translating PET readings into clinically useful statements. CONCLUSIONS: Although our results suggest that clinical experience with PET increases observers’ ability to read and interpret results from PET adequately, there is room for improvement. Experience with PET does not necessarily improve the accuracy of image interpretation. Springer-Verlag 2007-07-03 2007-09 /pmc/articles/PMC2039839/ /pubmed/17610119 http://dx.doi.org/10.1007/s11307-007-0108-1 Text en © Academy of Molecular Imaging 2007
spellingShingle Research Article
Smulders, Sietske A.
Gundy, Chad M.
van Lingen, Arthur
Comans, Emile F.
Smeenk, Frank W J M
Hoekstra, Otto S.
Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
title Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
title_full Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
title_fullStr Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
title_full_unstemmed Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
title_short Observer Variation of 2-Deoxy-2-[F-18]fluoro-d-Glucose-Positron Emission Tomography in Mediastinal Staging of Non-Small Cell Lung Cancer as a Function of Experience, and its Potential Clinical Impact
title_sort observer variation of 2-deoxy-2-[f-18]fluoro-d-glucose-positron emission tomography in mediastinal staging of non-small cell lung cancer as a function of experience, and its potential clinical impact
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2039839/
https://www.ncbi.nlm.nih.gov/pubmed/17610119
http://dx.doi.org/10.1007/s11307-007-0108-1
work_keys_str_mv AT smulderssietskea observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact
AT gundychadm observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact
AT vanlingenarthur observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact
AT comansemilef observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact
AT smeenkfrankwjm observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact
AT hoekstraottos observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact
AT observervariationof2deoxy2f18fluorodglucosepositronemissiontomographyinmediastinalstagingofnonsmallcelllungcancerasafunctionofexperienceanditspotentialclinicalimpact